
A new brain imaging study reveals that gadolinium-based contrast agent (GBCA) doses can be substantially reduced without risking image quality.
Read More

A new brain imaging study reveals that gadolinium-based contrast agent (GBCA) doses can be substantially reduced without risking image quality.
Read More
LET US PROVIDE YOU WITH THE LATEST MEDICAL NEWS, NETWORKING AND PROFESSIONAL DEVELOPMENT OPPORTUNITIES, AND EXCITING JOB OPENINGS FOR RADIOLOGISTS.
"*" indicates required fields
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.
Our team will contact you soon.

